Category Archives: Business and Investments

Latest From Business and Investments

BioNJ Streamlines Clinical Trials Agreement Process

bionj3

Biotechnology companies face monumental challenges – from containing R&D costs to managing sales and marketing to compliance with regulatory bodies. Biotech startups often operate with just a few employees, all of whom tend to pull double duty, both in the lab and front office. With that in mind, BioNJ has produced a free document available to companies (not just New Jersey-based ) interested in streamlining the often time-consuming process of negotiating clinical trial agreements. The Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , ,

Post-Con BIO CEO Company Snapshot: Immunovaccine

Immunovaccine-logo-PMS

A few weeks ago, the BIO CEO & Investor Conference concluded in New York City. With a 30% increase in One-on-One Partnering meetings and sold out company presentations, industry execs gathered to do business, and hear the latest from innovative companies. As a precursor to the event, the company snapshot campaign highlighted a few of the companies who would be participating onsite. This year, the snapshot feature concludes with an interview from Marc Mansour, Ph.D., Chief Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Participate in the 11th Annual Biopharmaceutical Manufacturing Report and Survey

Participate in the biopharmaceutical manufacturing industry’s most in-depth, global study: 11th Annual Biopharmaceutical Manufacturing Report and Survey. Your input is more important than ever, as BioPlan Associates benchmarks global and regional trends affecting the industry. You will receive a free summary of the results of the study as well as BioPlan’s 159 Key Industry Facts White Paper. For each completed survey BioPlan will donate $10 (up to $10,000) to global health charities. The survey takes Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: ,

The Economist – Biotechnology: Fever Rising

The-Economist-115x76

After speaking with several attendees and speakers at last week’s BIO CEO & Investor Conference, the Economist featured an article this week about the strong performance of biotech equities recently: AS INVESTORS and executives crammed into a New York ballroom for a conference held this week by the Biotechnology Industry Organisation, the mood was jittery. The previous week eight biotech firms had launched initial public offerings in America, together raising more than $500m. In a discussion Read More >

Business and Investments, Events  |  Leave a comment  |  Email This Post
Tags: , ,

Chicago Gets A New Health Care Incubator

Governor Pat Quinn is joined by civic and business leaders to announce MATTER - a new startup center for next-generation healthcare technology companies.

Illinois Governor Pat Quinn announced yesterday details about a new facility to support startup companies researching next-generation biopharma technology. The not-for-profit incubator, called MATTER, was a priority in the Governor’s 2014 State of the State address. The project is part of Governor Quinn’s funding package, administered through the Illinois Department of Commerce and Economic Opportunity (DCEO), that consists of a $2.5 million state investment and a loan of $1.5 million. Business leaders are also raising Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , ,